HUP9901786A2 - Eljárás helypreferált rákos áttétképződéssel kapcsolatos gének azonosítására immuno-mágneses sejtszeparáció felhasználásával - Google Patents

Eljárás helypreferált rákos áttétképződéssel kapcsolatos gének azonosítására immuno-mágneses sejtszeparáció felhasználásával

Info

Publication number
HUP9901786A2
HUP9901786A2 HU9901786A HUP9901786A HUP9901786A2 HU P9901786 A2 HUP9901786 A2 HU P9901786A2 HU 9901786 A HU9901786 A HU 9901786A HU P9901786 A HUP9901786 A HU P9901786A HU P9901786 A2 HUP9901786 A2 HU P9901786A2
Authority
HU
Hungary
Prior art keywords
sitepreferenced
methastasis
immuno
cancer
identification
Prior art date
Application number
HU9901786A
Other languages
English (en)
Inventor
Olav Engebrćten
Johannes Eivind Hoving
Anne Hansen Ree
Oystein Fodstad
Original Assignee
Oystein Fodstad
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oystein Fodstad filed Critical Oystein Fodstad
Publication of HUP9901786A2 publication Critical patent/HUP9901786A2/hu
Publication of HUP9901786A3 publication Critical patent/HUP9901786A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804—Nucleic acid analysis using immunogens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Eljárás helyspecifikűs vagy helypreferált expressziós génekazőnősítására őlyan célsejtekben, amelyeket eredetileg ismételtimműnő-mágneses eljárásőkkal ismertek fel és izőláltak. A tisztítőttcélsejteket ezűtán ismert klónőzási eljárásőknak vetik alá. Előnyöscélsejtek a rősszindűlatú sejtek, példáűl áttételes sejtek. Agénklónőzás végrehajtható a differenciális display vagy szűbtraktívhibridizációs megközelítéses módszer segítségével. ŕ
HU9901786A 1996-03-26 1997-03-25 Immuno-magnetic cell separation used in identification of genes associated with sitepreferenced cancer methastasis formation HUP9901786A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO961221A NO961221D0 (no) 1996-03-26 1996-03-26 Fremgangsmåte til å identifisere nye gener assosiert med setepreferert cancer mestastasedannelse

Publications (2)

Publication Number Publication Date
HUP9901786A2 true HUP9901786A2 (hu) 1999-09-28
HUP9901786A3 HUP9901786A3 (en) 2000-10-30

Family

ID=19899192

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9901786A HUP9901786A3 (en) 1996-03-26 1997-03-25 Immuno-magnetic cell separation used in identification of genes associated with sitepreferenced cancer methastasis formation

Country Status (19)

Country Link
EP (1) EP0894146B1 (hu)
JP (1) JP2000509250A (hu)
KR (1) KR19990087833A (hu)
CN (1) CN1214738A (hu)
AT (1) ATE251223T1 (hu)
AU (1) AU703262B2 (hu)
BR (1) BR9708256A (hu)
CA (1) CA2250202A1 (hu)
CZ (1) CZ286598A3 (hu)
DE (1) DE69725297T2 (hu)
HU (1) HUP9901786A3 (hu)
IL (1) IL126257A (hu)
NO (1) NO961221D0 (hu)
NZ (1) NZ331920A (hu)
PL (1) PL185182B1 (hu)
RU (1) RU2180963C2 (hu)
SK (1) SK282091B6 (hu)
TR (1) TR199801916T2 (hu)
WO (1) WO1997036004A1 (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9425138D0 (en) 1994-12-12 1995-02-08 Dynal As Isolation of nucleic acid
US6682940B2 (en) 1999-05-04 2004-01-27 Dan A. Pankowsky Products and methods for single parameter and multiparameter phenotyping of cells
US6828157B1 (en) 1999-05-04 2004-12-07 Dan A. Pankowsky Products and methods for single parameter and multiparameter phenotyping of cells
FR2804126B1 (fr) * 2000-01-21 2005-09-30 Patrick Rambaud Procede et systeme de gestion de lots de cellules immuno-competentes prelevees sur des sujets humains ou animaux en vue d'utilisations differees
AU2002214689A1 (en) * 2000-11-06 2002-05-15 Bio-Tech Imaging, Inc. Method and kits for detecting hepatitis infected cells
FR2816322A1 (fr) * 2000-11-06 2002-05-10 Epigene Methode de separation d'acide nucleique differemment exprime entre une cellule cible et une cellule de reference
CN115064209B (zh) * 2022-08-17 2022-11-01 普瑞基准科技（北京）有限公司 一种恶性细胞鉴定方法及系统

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2593192A (en) * 1992-09-14 1994-04-12 Oystein Fodstad Detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations
NO180658C (no) * 1994-03-10 1997-05-21 Oeystein Fodstad Fremgangsmåte og anordning for deteksjon av spesifikke målceller i spesialiserte eller blandede cellepopulasjoner og opplösninger som inneholder blandede cellepopulasjoner

Also Published As

Publication number Publication date
IL126257A (en) 2003-09-17
DE69725297T2 (de) 2004-08-05
WO1997036004A1 (en) 1997-10-02
HUP9901786A3 (en) 2000-10-30
CZ286598A3 (cs) 1999-02-17
SK141698A3 (en) 2000-01-18
RU2180963C2 (ru) 2002-03-27
KR19990087833A (ko) 1999-12-27
AU703262B2 (en) 1999-03-25
CN1214738A (zh) 1999-04-21
TR199801916T2 (xx) 1998-12-21
NZ331920A (en) 2000-01-28
NO961221D0 (no) 1996-03-26
PL185182B1 (pl) 2003-03-31
DE69725297D1 (de) 2003-11-06
JP2000509250A (ja) 2000-07-25
CA2250202A1 (en) 1997-10-02
EP0894146B1 (en) 2003-10-01
BR9708256A (pt) 1999-08-03
PL329038A1 (en) 1999-03-01
EP0894146A1 (en) 1999-02-03
IL126257A0 (en) 1999-05-09
AU2311697A (en) 1997-10-17
ATE251223T1 (de) 2003-10-15
SK282091B6 (sk) 2001-10-08

Similar Documents

Publication Publication Date Title
RO92633B (ro) Metoda de preparare a unui reactiv pentru identificarea acizilor nucleici
MXPA03002862A (es) Panel de diagnostico del cancer.
AU3568289A (en) Detection of neu gene expression and products
DE69636866D1 (en) Reverse "two-hybrid"-systeme
ATE91154T1 (de) Hybridisierungsverfahren zum nachweis genetischer stoffe.
EP0188450A4 (en) METHOD FOR DETECTING PATHOGENS OR GENETIC UNITS UNKNOWN IN VITRO AND DETERMINING.
TR199701462T1 (xx) DNA Dizisi ve bununla kodlanm�� meme'ye �zel g���s kanseri proteini.
HUP9901786A2 (hu) Eljárás helypreferált rákos áttétképződéssel kapcsolatos gének azonosítására immuno-mágneses sejtszeparáció felhasználásával
WO1997018454A3 (en) Method for identifying metastatic sequences
WO1994012881A3 (en) A method for detecting growing cells using translationally controlled tumor protein p21
Busch et al. Low-molecular-weight nuclear RNAs
MXPA03002864A (es) Portafolios de pronostico de cancer de mama.
ATE386130T1 (de) Adenovirale vektoren für die gentherapie
DE60016429D1 (de) Zell- und/oder tumor-spezifische promotor-abhängige änderung der gezielten expression des herpes gamma 34.5 gens
PT1058739E (pt) Metodo para produzir perfis de expressao genica
WO1990009457A3 (en) Oligonucleotide primer pairs for sequence independent gene amplification and methods which employ them
MXPA02004825A (es) Genes especificamente expresados en celulas dendriticas humanas.
HUP0203801A2 (hu) Eljárás rekombináns adenovírusok előállítására és adenovírus-könyvtárak
BR0012301A (pt) Inibidores de crescimento de células epiteliais
WO1993018151A1 (fr) Element transposable originaire d'une bacterie du genre brevibacterium
Morrow Lesbian identity development through group process: An exploration of coming out issues.
EP1214942A3 (de) Verwendung von mit Bacteriophagen, die ein tumorspezifisches und/oder tumorassoziliertes Antigen auf ihrer Oberfläche tragen, beladenen dendritischen Zellen zur Behandlung von Tumoren
Kowles Synthesis of two-chromosome double interchanges in N. crassa
Nielsen et al. Molecular Events of Ionizing Radiation on Specific Genes.
AU682278B2 (en) Oligomer carrier molecules in which marker groups and haptens are selectively incorporated